key: cord-329424-hmsidrc7
authors: Grunwell, Jocelyn R.; Stephenson, Susan T.; Mohammad, Ahmad F.; Jones, Kaitlin; Mason, Carrie; Opolka, Cydney; Fitzpatrick, Anne M.
title: Differential type I interferon response and primary airway neutrophil extracellular trap release in children with acute respiratory distress syndrome
date: 2020-11-04
journal: Sci Rep
DOI: 10.1038/s41598-020-76122-1
sha: 
doc_id: 329424
cord_uid: hmsidrc7

Acute respiratory distress syndrome (ARDS) is a heterogeneous condition characterized by the recruitment of large numbers of neutrophils into the lungs. Neutrophils isolated from the blood of adults with ARDS have elevated expression of interferon (IFN) stimulated genes (ISGs) associated with decreased capacity of neutrophils to kill Staphylococcus aureus and worse clinical outcomes. Neutrophil extracellular traps (NETs) are elevated in adults with ARDS. Whether pediatric ARDS (PARDS) is similarly associated with altered neutrophil expression of ISGs and neutrophil extracellular trap release is not known. Tracheal aspirate fluid and cells were collected within 72 h from seventy-seven intubated children. Primary airway neutrophils were analyzed for differential ISG expression by PCR, STAT1 phosphorylation and markers of degranulation and activation by flow cytometry. Airway fluid was analyzed for the release of NETs by myeloperoxidase-DNA complexes using an ELISA. Higher STAT1 phosphorylation, markers of neutrophil degranulation, activation and NET release were found in children with versus without PARDS. Higher NETs were detected in the airways of children with ventilator-free days less than 20 days. Increased airway cell IFN signaling, neutrophil activation, and NET production is associated with PARDS. Higher levels of airway NETs are associated with fewer ventilator-free days.

| (2020) 10:19049 | https://doi.org/10.1038/s41598-020-76122-1 www.nature.com/scientificreports/ We have previously demonstrated that neutrophils exposed to airway fluid from mechanically ventilated children with virally-induced respiratory failure and bacterial coinfection have decreased respiratory burst and bacterial killing capacity 8 . However, the mechanisms underlying these observations are still unclear. Respiratory viruses have been shown to induce type I interferon (IFN) (IFNα/β) responses that then upregulate expression of interferon-stimulated genes (ISGs) such as MX1, ISG15, and IFIT1 9,10 , which influence neutrophil behavior and function 5, 6 . Since viral lower respiratory tract infections are a primary trigger for PARDS, we questioned whether differential ISG expression was associated with neutrophil responses in intubated children at risk or with PARDS. We hypothesized that children with PARDS would have a greater type I IFN response resulting in more neutrophil extracellular trap (NET) release.

This prospective, observational study was performed in the thirty-six-bed academic medical/surgical Pediatric Intensive Care Unit (PICU) at Emory University/Children's Healthcare of Atlanta at Egleston from January 2018 through February 2020. The study was approved by the Institutional Review Board at Emory University (IRB 00034236 and IRB 00113035) and all methods were carried out in accordance with relevant guidelines and regulations in the Declaration of Helsinki. Informed consent was obtained from the parents of all subjects prior to collection and use of their samples.

All patients admitted to the PICU who were greater than 2 days, with a corrected gestational age of at least 40 weeks, and were younger than 18 years old that met criteria for being at risk or having PARDS, as defined by the Pediatric Acute Lung Injury Consensus Conference (PALICC), were screened for eligibility 11 . Children had to have lung injury within 7 days of a known clinical insult, new infiltrate(s) consistent with acute pulmonary parenchymal disease on chest imaging and be receiving oxygen delivered either noninvasively or invasively to maintain an oxygen saturation between 88 and 97%. Children were excluded if they had any peri-natal related lung disease, respiratory failure fully explained by cardiac failure or fluid overload, chronic respiratory failure with mechanical ventilation via a tracheostomy or RAM cannula, confirmed immunodeficiency disorder, immunosuppression from chemotherapy for an oncologic process, chronic immunosuppression in a bone marrow transplant or solid organ transplant recipient, no parent or legal guardian present to provide written informed consent, or the attending physician did not wish the patient to participate in the study. Children were enrolled as controls if they were endotracheally intubated for airway protection and without lung pathology or signs of systemic infection or inflammation. For example, children selected as controls were electively intubated to facilitate radiologic imaging, for non-airway or cardiothoracic surgeries, and for airway protection following an acute ingestion or altered mental status without suspicion for infection or systemic inflammation.

Clinical data were abstracted from the medical record onto a standardized form. Variables included demographics; fraction inspired oxygen, mean airway pressure, arterial oxygen saturation or arterial oxygen pressure used to calculate an oxygen saturation index (OSI) or oxygenation index (OI), respectively; laboratory and microbiology results; length of mechanical ventilation and need for reintubation; length of PICU stay, use of high frequency oscillatory ventilation (HFOV) or extracorporeal life support (ECLS), and vital status. Severity of illness was determined by the Pediatric Risk of Mortality (PRISM)-III and pediatric Logistic Organ Dysfunction (PELOD) scores were calculated within 24 h of intubation 12, 13 . Need for mechanical ventilation to 28-days was monitored to calculate ventilator-free days 14 . Lung injury severity was categorized according to PALICC criteria 11 . Tracheal aspirate collection. Tracheal aspirates were obtained from patients on conventional mechanical ventilation by instilling 1-5 mL of sterile saline through the inline Ballard suction catheter and into a sterile Luken's trap as part of routine suctioning per published protocols 8 . Children who were mechanically ventilated with HFOV were suctioned only if clinically indicated and approved by the attending physician. Tracheal aspirate samples were immediately placed on ice for transport to the laboratory for processing. Airway sample processing. Tracheal aspirate was gently dissociated using repeated passage through an 18G needle after the addition of 6 ml of PBS-EDTA. Dissociated tracheal aspirate was then centrifuged at 800×g to generate a cell pellet and a fluid fraction. The fluid fraction was spun at 3000×g to generate cell-free airway supernatant (ASN), aliquoted, and stored at − 80 °C 8 . Airway cells were resuspended in PBS-EDTA and cell density was quantified using a Countess hemocytometer using trypan blue exclusion to determine cell viability. Cell purity was also assessed by cytospin preparations and Diff-Quik staining of airway cells. Cell viability was also assessed using a Live/Dead Aqua stain in the surface staining flow cytometry panel.

Gene expression assays. RNA was isolated from airway cells stored at − 80 C in RNA Later using the NucleoSpin RNA II kit with on-column genomic DNA digestion according to the manufacturer's protocol (Takara, Mountain View, CA). RNA was quantified using a NanoDrop Fluorospectrometer (Therma Scientific). RNA integrity (RIN) was measured at the Emory Integrated Genomics Core on an Agilent 2100 bioanalyzer (see Supplementary Table S1 Statistical analysis. Statistical analyses were performed using JMP Pro 14 (SAS Institute, Cary, NC) and

GraphPad Prism 8 for Windows. Unless otherwise stated, comparisons between samples of children with versus without PARDS were made using a two-tailed Mann-Whitney U test for nonparametric data. For PCR studies, a ROUT outlier test using a 1% false discovery rate was performed prior to a two-tailed Mann-Whitney U test. Statistical significance was defined as a p value less than 0.05.

Subject characteristics. Seventy-seven patients were enrolled into the study within 72 h of intubation and mechanical ventilation. Of these 77 children, 42 (54.6%) had PARDS and 35 (45.4%) did not have PARDS. Table 1 shows the demographics and clinical characteristics of the 77 enrolled patients. The respiratory viral PCR panel and respiratory culture results from the clinical microbiology lab are reported in Supplementary  Table S2 online. Children with PARDS were more likely to be supported by extracorporeal life support (ECLS), had a longer duration of mechanical ventilation, and spent more days in the hospital and the PICU (Table 1) . There were no significant differences in severity of illness (PRISM III) or organ dysfunction (PELOD) scores, the absolute number or percentage of alive neutrophils from children based on PARDS status (Table 1) .

This study was a survey of the activation status of neutrophils is PARDS. We assessed markers of airway neutrophil activation by flow cytometry. The gating strategy for selecting airway neutrophils is shown (Fig. 1A-C) . There was no difference in total number (Fig. 1D ) or percent CD66b + neutrophils (Fig. 1E ) in intubated children with or without PARDS. Children with PARDS also had increased neutrophil surface expression of CD63, a marker of primary granule exocytosis (Fig. 1F) , and sphingosine 1-phosphate receptor 3 (S1PR3), a protein that forms a heterodimer with the neutrophil IL8-induced chemotaxis receptor, CXCL1, and is detected with increased abundance in blood neutrophils from adults with bacterial pneumonia (Fig. 1G ) 16 . There was no significant difference in surface expression of the type III Fcγ receptor, CD16 or arginase I (Arg1), an enzyme stored in the primary and tertiary granules of human neutro- www.nature.com/scientificreports/ phils ( Fig. 1H-I) . Examples of cytospin preparations stained with Diff-Quik from four unique patient tracheal aspirates show the predominance of neutrophils in the airway samples (Fig. 1J) . We next determined whether the type I interferon (IFNα/β) signaling pathway was activated by measuring the phosphorylation of signal transducer and activator of transcription 1 (STAT1) by intracellular staining of fixed airway samples. Airway cells from children with PARDS had increased expression of phosphorylated-Y701 STAT1 (P-STAT1) and STAT1 compared with children who did not meet PARDS criteria (Fig. 2) . Cells were gated on forward and side scatter and representative histograms for both P-STAT1 and STAT1 are shown ( Fig. 2A) . Quantification of both the mean fluorescence intensity (MFI) and percent positive cells are summarized in Fig. 2B -E. Children with PARDS have higher levels of STAT1 and P-STAT1 compared with children without PARDS. Activation of the type I interferon signaling pathway results in increased expression of many www.nature.com/scientificreports/ www.nature.com/scientificreports/ IFN-stimulated genes (ISGs) 17 . Three ISGs, IFIT1, ISG15, and Mx1, were used to identify activation the type I IFN signaling pathway 5, 6 . ISG expression of children with versus without PARDS were compared. ISG expression was variable; however, children with PARDS did not show a significant difference in expression level of ISG15, IFIT1 or Mx1 compared to children without PARDS (Fig. 3) . Our results show that markers of neutrophil degranulation and activation are elevated in children with versus without PARDS. In addition, activation of the type I IFN signaling pathway, as indicated by increases in P-STAT1, and ISG15 expression occurs in some children with PARDS. (Fig. 4A) . Higher airway NET levels were associated with fewer ventilator-free days (F = 21.20, p value < 0.0001), a lower proportion of children with ventilator-free days over 20 days (Fig. 4B) 

Acute LRTI are the trigger for the majority of PARDS 1 . Viral and bacterial infections activate type I IFN signaling pathways resulting in an increase in antiviral ISG expression and proinflammatory responses critical for host defense 10, 19 . A finely tuned type I IFN response is crucial to a host as an excessive or prolonged type I IFN response may lead to impaired gas exchange in the lung due to cellular and tissue destruction 20 . IFNs prime mature neutrophils for NET release upon stimulation with a second stimulatory signal 21 . Although antimicrobial proteins expressed on NETs can inactivate pathogens and prevent viral spread to neighboring cells, the lung is www.nature.com/scientificreports/ vulnerable to the damage that histones and proteolytic enzymes contained within NETs can inflict to host tissue. Therefore, excessive and prolonged type I IFN signaling may contribute to the production of NETs which fill the alveolar spaces, lead to increased inflammation, and result in impaired lung function, which are the hallmarks of PARDS. Our study assessed neutrophil activation, the differential expression of ISGs and activation of the STAT1 signaling pathway, and NETosis in the airways of intubated children with acute respiratory failure due to lower respiratory tract infections. We found increased neutrophil degranulation markers, phosphorylation of STAT1 (Y701), and NETs, as measured by MPO-DNA complexes, in the airways of children with PARDS compared with children without PARDS. Higher levels of airway NETs were associated with fewer ventilator-free days. Our findings are summarized in Fig. 5 . The timing and magnitude of the type I IFN response are important in modulating the immune response to viral infection 22, 23 . At higher levels, ISGs contribute to dysregulated lung inflammation, disease progression, and are linked to worse clinical outcomes 20 . For example, in a mouse model of SARS-CoV infection, the delayed expression of high levels of type I IFN in the presence of high viral titers resulted in lethal pneumonia 22 ; however, early treatment with type I IFN within the first six hours of SARS-CoV infection was protective. In Influenza A virus, disease severity and progression are associated with overshooting the IFN-driven inflammatory response whereby exogenous supplementation with type I IFN correlated with increased morbidity and mortality 24, 25 . RSV also induces high levels of pro-inflammatory cytokines directly related to type I IFN, and mice that lack IFNAR have less proinflammatory cytokine release resulting in a less severe disease course following RSV infection 26 . By contrast, there was no effect of IFNAR deletion on pathogenicity of mice infected with SARS-CoV; however, STAT1 deficient mice showed increased susceptibility, prolonged viral shedding and mortality 27 .

Differential type I IFN and ISG expression are associated with neutrophil dysfunction and worse clinical outcomes 5, 6 . For example, high expression of a panel of ISGs (MX1, IFIT1, ISG15) from circulating neutrophils from a subgroup of adults with ARDS compared with normal ISG expressing neutrophils had reduced migration toward the neutrophil chemokine interleukin-8 (IL-8), decreased p38 MAP kinase phosphorylation, superoxide anion release, IL-8 release, and a shift from necrotic to apoptotic cell death that was associated with a diminished capacity to kill Staphylococcus aureus, but not Pseudomonas 5 . Subsequent hierarchal clustering analysis of the aforementioned ISG panel from circulating neutrophils of ARDS patients within 72 h of initiation of mechanical Surface expression of the primary granule exocytosis marker, CD63, and the lipid signaling G protein-coupled receptor, sphingosine-1-phosphate receptor 3 (S1PR3), are higher in children with versus without PARDS. The type I interferon (IFN) signaling pathway transcription factor, STAT1, is upregulated and phosphorylated, and transcript levels of ISG15 is increased in children with versus without PARDS. Neutrophil extracellular trap (NET) release is regulated by a NADPH oxidase (NOX) respiratory burst (reactive oxygen species (ROS) triggered mechanism and an intracellular calcium-dependent trigger. It is not known which trigger dominates in the airways of children with PARDS. Children with PARDS have elevated levels of NETs in their airways as detected by myeloperoxidase (MPO)-DNA complexes in our study. Elevated NET levels are associated with a higher number of ventilator-free days (VFD) over 20 days in a 28-day period (i.e. if the child survived, then they were more likely to spend ≥ 7 days endotracheally intubated and mechanically ventilated). Created with BioRender.com using the web version, which may be accessed at https ://biore nder.com/, with a paid individual subscription granting permission to publish in journals.

| (2020) 10:19049 | https://doi.org/10.1038/s41598-020-76122-1 www.nature.com/scientificreports/ ventilation showed that both High-and Low-range expression had fewer 28-day ventilator-free and ICU-free days and higher 90-day mortality compared with Mid-range ISG expressing patients 6 . These data suggest that a targeted middle ground for IFN levels exists to benefit the host. An IFN signal below a lower threshold would result in an ineffective antiviral host response, while an IFN signal above an upper threshold would trigger a detrimental inflammatory host response. IFN signaling outside the target zone would increase lung inflammation and ARDS severity 5, 6, 20 . By contrast, our findings are from airway cells with a neutrophil predominance rather than from circulating neutrophils for adults with ARDS 5,6 . Additionally, we assessed each ISG, IFIT1, ISG15, and Mx1, individually rather than in aggregate, and we note that ISG expression is highly variable in children with versus without PARDS. Finally, the release of NETs was not assessed in the aforementioned studies.

Excessive NET formation has been reported in the serum and bronchoalveolar lavage fluid from adults with ARDS; however conclusions with respect to clinically relevant outcomes are difficult to draw due to the heterogeneity in study design 18, 28, 29 . NETs play prominent roles in bacterial pneumonia [30] [31] [32] , RSV bronchiolitis 33, 34 , influenza pneumonia 31, 35, 36 , sepsis [37] [38] [39] [40] , SARS-CoV2 41 , small-vessel vasculitis 15 , systemic lupus erythematosus 42, 43 , and transfusion-related acute lung injury 44 . NETs induce dose-dependent cytotoxic effects on human alveolar epithelial cells due to histone and myeloperoxidase induced damage to alveolar epithelial and endothelial cells 45, 46 . NETs also influence the macrophage function 47 , T cell proliferation 48 , and amplify IFN production by plasmacytoid dendritic cells 42 . Conversely, interferons influence the process of NETosis in mature neutrophils 21, 49 .

High IFN/ISG expression polarizes neutrophils to an activated "N1" phenotype that can lead to increased NET production, degranulation, and influence neutrophil interactions with other immune and airway epithelial cells 50 . Interferonopathies, autoimmune diseases, and tumor-associated neutrophils are all examples where high IFN/ISG levels influence neutrophil activation and function 42, 51 . Priming of neutrophils with IFN-α and subsequent stimulation with C5a resulted in increased STAT1 phosphorylation at tyrosine 701 and NET production in mature neutrophils 21 . Activation of neutrophils by type I IFNs led to increased NETosis that triggered biofilm formation by Pseudomonas aeruginosa and persistence in the lung 50 . NET production, like IFN signaling, exists in a balance. Excessive NET release can lead to the systemic spread of inflammation through platelet interactions and result in multiple organ dysfunction 37, 39, 52 ; however, depletion or defective NET production can lead to the spread of infection early in the course of disease 40 .

Several mechanisms regulating the formation of NETs are known and include NADPH oxidase (NOX2) dependent and calcium channel NOX-independent NETosis 53-56 . NETosis is driven by NET-specific kinases that regulate transcription initiation in neutrophils. For example, ERK was shown to differentially regulate NOXdependent NETosis 54 . Interestingly, Khan and colleagues also noted that STAT1 was a transcription factor that was upregulated in the NOX-dependent NETosis pathway 54 . We were not able to study the relative importance of NOX-dependent versus calcium influx (NOX-independent) mechanisms on NET formation given that NETosis has already occurred by the time of tracheal aspirate sampling in our patients. Additionally, we did not quantify the relative amounts of neutrophils undergoing NETosis versus apoptosis. Quantifying neutrophil apoptosis should be part of future studies as NOX-dependent NETosis is dependent on the activation of the kinase Akt to suppress apoptosis and switch to NETosis 57 .

While we detected higher type I IFN signaling and NET production in the airways of children with versus without PARDS, due to the clinical nature of our study, we are not able to attribute causation of neutrophil dysfunction to high ISG expression in study participants. There are several additional limitations to our study. First, this is a single-center study with a limited sample size; however, despite the limited number of children studied, we were able to detect differences in neutrophil type I IFN signaling pathway phosphorylation and function in intubated children with versus without PARDS. The majority of children in this study were at risk for developing PARDS, with the remaining children being equally distributed amongst mild, moderate and severe PARDS categories; however, the degree of PARDS severity was not associated with neutrophil dysfunction due to heterogeneity in neutrophil function and a limited sample size. We also excluded immunocompromised patients from our study which is a major risk factor associated with PARDS-related mortality [58] [59] [60] . Second, there is heterogeneity in the identity of viral and bacterial pathogens infecting study participants precluding any conclusions regarding the influence of organism on study results. We did not stratify the patients based on bacterial growth in an endotracheal respiratory culture as there is controversy regarding whether this is a true bacterial coinfection versus merely codetection of bacterial and viral organisms 61 . Thirdly, we are not powered to detect differences in mortality associated with higher ISG gene expression as seen in the adult ARDS cohort; however, we did detect a significant difference in ventilator-free days in children with a higher airway NET burden 6 . We are limited in the ability to study the mechanisms regulating airway NET release as NETosis has already occurred in patients at the time of sample collection' however, network analysis of transcription factor signaling pathways from recovered airway neutrophils could be performed as previously described 54 . Additionally, future experiments using blood-derived neutrophils from healthy donors could be incubated in patient airway fluid to simulate the airway environment with PMA and calcium-ionophore stimulation, and appropriate NOX inhibition, to study mechanistic regulation of NET formation. Finally, we did not explore the role of other signaling pathways, such as that initiated through the sphingolipid receptor or other kinase signaling cascades, as mechanisms involved in the pathogenesis of NETs or PARDS severity.

In summary, we describe the differential type I IFN signaling based on the presence or absence of PARDS and show that airway levels of NETs are higher in children with versus without PARDS. Higher levels of airway NETs are associated with fewer ventilator-free days. Future work will explore the influence of type I IFN signaling, NETs and the PARDS airway environment on macrophage and T-cell activation and function. Defining underlying mechanistic differences in children with acute respiratory failure due to lower respiratory tract infections is needed to move beyond supportive care and toward targeted personalized therapies for pediatric patients with moderate/severe PARDS.

| (2020) 10:19049 | https://doi.org/10.1038/s41598-020-76122-1 www.nature.com/scientificreports/

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Received: 18 July 2020; Accepted: 22 October 2020

Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study

The acute respiratory distress syndrome

Acute respiratory distress syndrome

A role for neutrophils in viral respiratory disease

Bacteria-specific neutrophil dysfunction associated with interferon-stimulated gene expression in the acute respiratory distress syndrome

Extremes of interferon-stimulated gene expression associate with worse outcomes in the acute respiratory distress syndrome

Contribution of neutrophils to acute lung injury

Neutrophil dysfunction in the airways of children with acute respiratory failure due to lower respiratory tract viral and bacterial coinfections

Innate recognition of viruses

Type I interferons in host defense

Pediatric Acute Lung Injury Consensus Conference, G. Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference

PELOD-2: an update of the pediatric logistic organ dysfunction score

PRISM III: an updated pediatric risk of mortality score

Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome

Netting neutrophils in autoimmune small-vessel vasculitis

Neutrophil sphingosine 1-phosphate and lysophosphatidic acid receptors in pneumonia

Regulation of type I interferon responses

Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia

Type I interferons as regulators of lung inflammation

The impact of the interferon/TNF-related apoptosis-inducing ligand signaling axis on disease progression in respiratory viral infection and beyond

Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation

Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected Mice

IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes

Pathogenic potential of interferon alphabeta in acute influenza infection

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection

SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism

Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS

Neutrophil extracellular traps are elevated in patients with pneumonia-related acute respiratory distress syndrome

Capsules of virulent pneumococcal serotypes enhance formation of neutrophil extracellular traps during in vivo pathogenesis of pneumonia

In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection. Front. Immunol. 4, 56

Nontypeable Haemophilus influenzae initiates formation of neutrophil extracellular traps

Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease

Respiratory syncytial virus fusion protein promotes TLR-4-dependent neutrophil extracellular trap formation by human neutrophils

Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis

High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza A infection

Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis

Neutrophil extracellular traps in sepsis

Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis

Neutrophil extracellular traps in patients with sepsis

Neutrophil extracellular traps in COVID-19

Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupuslike disease

Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice

Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones

The role of extracellular histones in influenza virus pathogenesis

NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization

T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses

The essential role of type I interferons in differentiation and activation of tumor-associated neutrophils

Detrimental effect of type I IFNs during acute lung infection with Pseudomonas aeruginosa is mediated through the stimulation of neutrophil netosis

A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs

Neutrophil extracellular traps promote hypercoagulability in patients with sepsis

SK3 channel and mitochondrial ROS mediate NADPH oxidaseindependent NETosis induced by calcium influx

Transcriptional firing helps to drive

Hypertonic saline suppresses NADPH oxidase-dependent neutrophil extracellular trap formation and promotes apoptosis

Alkaline pH promotes NADPH oxidase-independent neutrophil extracellular trap formation: a matter of mitochondrial reactive oxygen species generation and citrullination and cleavage of histone. Front. Immunol. 8, 1849

Akt is essential to induce NADPH-dependent NETosis and to switch the neutrophil death to apoptosis

A simple and robust bedside model for mortality risk in pediatric patients with acute respiratory distress syndrome

Predicting mortality in children with pediatric acute respiratory distress syndrome: a pediatric acute respiratory distress syndrome incidence and epidemiology study

Subtypes of pediatric acute respiratory distress syndrome have different predictors of mortality

Pediatric ventilator-associated infections: the ventilator-associated infection study

We acknowledge the Emory + Children's Flow Cytometry Core for flow cytometry instrumentation. This study was supported in part by the Emory Integrated Genomics Core (EIGC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. Additional support was provided by the Georgia Clinical and Translational Science Alliance of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health. The authors thank the bedside caregivers of the patients involved in this study for their skilled and compassionate care.

J.G. and A.F. conceived and developed the study, supervised the acquisition of the biological data, analyzed and interpreted the data. J.G. drafted and edited the manuscript. A.F. assisted with drafting and editing the manuscript. S.S. and A.M. helped with patient sample processing, performed experiments and helped to interpret the data. K.J. and C.O. assisted in identifying, consenting, acquiring patient samples. K.J., C.O., and C.M. assisted in collecting clinical information about the patients. All authors edited and approved the final version of this manuscript.

Drs. Grunwell and Fitzpatrick received support for research from the National Institutes of Health. Funding was provided by NIH grants K12HD072245 (Atlanta Pediatric Scholars Program), K23 HL151897-01, and an Emory University Pediatrics Research Alliance Junior Faculty Focused Pilot award to JG.

The authors declare no competing interests.

Supplementary information is available for this paper at https ://doi.org/10.1038/s4159 8-020-76122 -1.Correspondence and requests for materials should be addressed to J.R.G.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.